69 related articles for article (PubMed ID: 11120548)
1. Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience.
Pagnano KB; Traina F; Takahashi T; Oliveira GB; Rossini MS; Lorand-Metze I; Vigorito AC; Miranda EC; De Souza CA
Sao Paulo Med J; 2000 Nov; 118(6):173-8. PubMed ID: 11120548
[TBL] [Abstract][Full Text] [Related]
2. [Clinical characteristics and prognosis of patients with therapy-related myelodysplastic syndrome and acute myeloid leukemia arising from malignant tumors].
Xu XS; Ding H; Zhang X; Liao Y; Li H; Liu QY; Liu JZ; Zhang L; Huang J; Gong YP; Ma HB; Xiang B; Dai Y; Hou L; Shuai X; Niu T; Wu Y
Zhonghua Xue Ye Xue Za Zhi; 2023 Sep; 44(9):742-748. PubMed ID: 38049318
[No Abstract] [Full Text] [Related]
3. Transformation from acute promyelocytic leukemia in pregnancy to acute myeloid leukemia with MLL-AF9 fusion gene: A case report and literature review.
Gao Y; Han N; Jiang Y; Lu Z
Medicine (Baltimore); 2023 Dec; 102(48):e36403. PubMed ID: 38050244
[TBL] [Abstract][Full Text] [Related]
4. Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia.
Zhang Y; Wu Q; Yuan B; Huang Y; Jiang L; Liu F; Yan P; Jiang Y; Ye J; Jiang X
BMC Cancer; 2023 Oct; 23(1):1030. PubMed ID: 37875840
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the clinical characteristics of acute myeloid leukemia related to the treatment of hematological and solid tumors].
Jiao Y; Jiang YH; Liu B; Mi RH; Bi LJ; Xu QX
Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):86-95. PubMed ID: 38246784
[No Abstract] [Full Text] [Related]
6. Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience.
Sobas M; Knopinska-Posluszny W; Piątkowska-Jakubas B; García-Álvarez F; Díez MEA; Caballero M; Martínez-Cuadrón D; Aguiar E; González-Campos J; Garrido A; Algarra L; Salamero O; de la Serna J; Sayas MJ; Perez-Encinas MM; Vives S; Vidriales B; Labrador J; Prado AI; Celebrin L; Mayer J; Brioso J; de Laiglesia A; Bergua JM; Amigo ML; Rodriguez-Medina C; Polo M; Pluta A; Cichocka E; Skarupski M; Sanz MA; Wierzbowska A; Montesinos P
Ann Hematol; 2024 Feb; 103(2):451-461. PubMed ID: 38110588
[TBL] [Abstract][Full Text] [Related]
7. [Clinical effect of the SCMC APL-2010 regimen in treatment of acute promyelocytic leukemia in children: an analysis of 44 cases].
Wang Z; Shen SH; Tang YJ; Xue HL; Hu WT; Pan C; Tang JY; Gu LJ; Chen J
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Nov; 21(11):1073-1078. PubMed ID: 31753087
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of therapy-related acute myeloid leukemia patients. Real-life experience in a University Hospital and a Cancer Center in France.
Belhabri A; Heiblig M; Morisset S; Vila L; Santana C; Nicolas-Virelizier E; Hayette S; Tigaud I; Plesa A; Labussiere-Wallet H; Sobh M; Michallet AS; Marie B; Nicolini FE; Guillermin Y; Gaëlle F; Lebras L; Rey P; Jauffret-Bertholon L; Laude MC; Sandrine L; Michallet M
Cancer Med; 2023 Aug; 12(16):16929-16944. PubMed ID: 37548369
[TBL] [Abstract][Full Text] [Related]
9. A Survival Analysis of Acute Myeloid Leukemia Patients Treated With Intensive Chemotherapy: A Single Center Experience.
Jimbu L; Valeanu M; Trifa AP; Mesaros O; Bojan A; Dima D; Parvu A; Rus IC; Tomuleasa C; Torok T; Urian L; Vasilache A; Zdrenghea M
Cureus; 2023 Aug; 15(8):e43794. PubMed ID: 37731446
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France.
Alcazer V; Le Meur G; Roccon M; Barriere S; Le Calvez B; Badaoui B; Spaeth A; Kosmider O; Freynet N; Eveillard M; Croizier C; Chevalier S; Sujobert P
Lancet Digit Health; 2024 May; 6(5):e323-e333. PubMed ID: 38670741
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of patients with acute myeloid leukemia and cardiovascular disease.
Sanchez-Petitto G; Goloubeva OG; Masur J; Childress J; Iqbal T; An M; Muhammad S; Lawson J; Li G; Barr B; Emadi A; Law JY; Lee ST; Duong VH; Baer MR; Niyongere S
Leuk Res; 2024 Mar; 138():107456. PubMed ID: 38442593
[TBL] [Abstract][Full Text] [Related]
12. A convolutional neural network-based, quantitative complete blood count scattergram-mapping framework promptly screens acute promyelocytic leukemia with high sensitivity.
Liao H; Xu Y; Meng Q; Mao Z; Qiao Y; Liu Y; Zheng Q
Cancer; 2023 Oct; 129(19):2986-2998. PubMed ID: 37254628
[TBL] [Abstract][Full Text] [Related]
13. The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment.
De Stefano V; Sorà F; Rossi E; Chiusolo P; Laurenti L; Fianchi L; Zini G; Pagano L; Sica S; Leone G
J Thromb Haemost; 2005 Sep; 3(9):1985-92. PubMed ID: 16102104
[TBL] [Abstract][Full Text] [Related]
14. A critical evaluation of the EFS endpoint in AML: Does induction treatment failure timing have a profound impact on study design and results?
Sidi Y; Dong C; Wu Y; Faller DV
Leuk Res; 2024 Mar; 138():107465. PubMed ID: 38422881
[TBL] [Abstract][Full Text] [Related]
15. The impact of remission status on patients' experiences with acute myeloid leukemia (AML): an exploratory analysis of longitudinal patient-reported outcomes data.
Kayastha N; Wolf SP; Locke SC; Samsa GP; El-Jawahri A; LeBlanc TW
Support Care Cancer; 2018 May; 26(5):1437-1445. PubMed ID: 29151174
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Gene Rearrangement by Multiplex PCR in De Novo Acute Myeloid Leukemia in Adult Iraqi Patients.
AlJabban A; Alalsaidissa J
J Blood Med; 2023; 14():445-453. PubMed ID: 37588276
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of
Lucena-Araujo AR; Pereira-Martins DA; Koury LC; Franca-Neto PL; Coelho-Silva JL; de Deus Wagatsuma VM; Melo RAM; Bittencourt R; Pagnano K; Pasquini R; Chiattone CS; Fagundes EM; Chauffaille ML; Schrier SL; Tallman MS; Ribeiro RC; Grimwade D; Ganser A; Löwenberg B; Lo-Coco F; Sanz MA; Berliner N; Rego EM
Blood Adv; 2017 Sep; 1(21):1807-1814. PubMed ID: 29296827
[TBL] [Abstract][Full Text] [Related]
18. [Incidence of newly diagnosed adult acute leukemia in Fujian province from 2011 to 2012].
Clinical Collaborative Group of Fujian Medical Association Hematological Branch
Zhonghua Xue Ye Xue Za Zhi; 2015 Sep; 36(9):733-8. PubMed ID: 26462771
[TBL] [Abstract][Full Text] [Related]
19. High GLI-1 Expression is a Reliable Indicator of Bad Prognosis in Newly Diagnosed Acute Leukemia Patients.
El Zaiat RS; Nabil R; Khalifa KA; El Feshawy AA
Indian J Hematol Blood Transfus; 2023 Jul; 39(3):376-382. PubMed ID: 37304485
[TBL] [Abstract][Full Text] [Related]
20. Optimizing antimicrobial prophylaxis strategies in acute leukemia patients: Assessing the efficacy of fluconazole.
Teran NS; Park GS
J Oncol Pharm Pract; 2023 Nov; ():10781552231212204. PubMed ID: 37936404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
